81 related articles for article (PubMed ID: 1868443)
21. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
Saito S; Tatsumoto T; Lorenzi MV; Chedid M; Kapoor V; Sakata H; Rubin J; Miki T
J Cell Biochem; 2003 Nov; 90(4):819-36. PubMed ID: 14587037
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
23. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
Futscher BW; Erickson LC
Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
Eager KB
Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
Trojanowska M; Wu LT; LeRoy EC
Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
[TBL] [Abstract][Full Text] [Related]
27. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
[TBL] [Abstract][Full Text] [Related]
28. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
29. Ischemic induction of protooncogene expression in gerbil brain.
Kindy MS; Carney JP; Dempsey RJ; Carney JM
J Mol Neurosci; 1991; 2(4):217-28. PubMed ID: 1905565
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the expression of the c-fos proto-oncogene in the rat cerebral cortex during learning].
Maleeva NE; Ivolgina GL; Anokhin KV; Limborskaia SA
Genetika; 1989 Jun; 25(6):1119-21. PubMed ID: 2509287
[TBL] [Abstract][Full Text] [Related]
31. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
32. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli.
Grumont RJ; Gerondakis S
Oncogene Res; 1990; 5(4):245-54. PubMed ID: 2204017
[TBL] [Abstract][Full Text] [Related]
33. Activation of a mcf.2 oncogene by deletion of amino-terminal coding sequences.
Noguchi T; Galland F; Batoz M; Mattei MG; Birnbaum D
Oncogene; 1988 Dec; 3(6):709-15. PubMed ID: 2577874
[TBL] [Abstract][Full Text] [Related]
34. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells.
Ron D; Tronick SR; Aaronson SA; Eva A
EMBO J; 1988 Aug; 7(8):2465-73. PubMed ID: 3056717
[TBL] [Abstract][Full Text] [Related]
36. Cell transformation by dbl oncogene.
Zangrilli D; Eva A
Methods Enzymol; 1995; 256():347-58. PubMed ID: 7476452
[No Abstract] [Full Text] [Related]
37. The predicted DBL oncogene product defines a distinct class of transforming proteins.
Eva A; Vecchio G; Rao CD; Tronick SR; Aaronson SA
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2061-5. PubMed ID: 3281159
[TBL] [Abstract][Full Text] [Related]
38. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation.
Notario V; Gutkind JS; Imaizumi M; Katamine S; Robbins KC
J Cell Biol; 1989 Dec; 109(6 Pt 1):3129-36. PubMed ID: 2687293
[TBL] [Abstract][Full Text] [Related]
39. The myc family of nuclear proto-oncogenes.
Lee WM
Cancer Treat Res; 1989; 47():37-71. PubMed ID: 2577005
[TBL] [Abstract][Full Text] [Related]
40. Dbl expression driven by the neuron specific enolase promoter induces tumor formation in transgenic mice with a p53(+/-) genetic background.
Colucci-D'Amato GL; Santelli G; D'Alessio A; Chiappetta G; Mineo A; Manzo G; Vecchio G; de Franciscis V
Biochem Biophys Res Commun; 1995 Nov; 216(3):762-70. PubMed ID: 7488191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
